Home ›
Organizations ›
EVIDENCE FOR HEALTHCARE IMPROVEMENT
EVIDENCE FOR HEALTHCARE IMPROVEMENT
MA · Healthcare · EIN 463250612
32
Executives Disclosed
$9.2M
Annual Revenue
$11.9M
Total Assets
2.7:1
Internal Pay Ratio
EVIDENCE FOR HEALTHCARE IMPROVEMENT has 32 executives with disclosed compensation. The highest-paid executive, Steven D Pearson (PRESIDENT), received peak total compensation of $601,631. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Steven D Pearson | PRESIDENT | $602K | $602K | 2016–2023 | 8x |
| Sarah K Emond | PRESIDENT & CEO | $526K | $526K | 2016–2024 | 7x |
| David Rind | CHIEF MEDICAL OFFICER | $426K | $426K | 2016–2024 | 5.7x |
| Daniel Ollendorf | CHIEF SCIENTIFIC OFFICER | $367K | $367K | 2024–2024 | 4.9x |
| Jonathan Campbell | SR VP HEALTH ECON. UNTIL 7/23 | $357K | $208K | 2021–2023 | 4.8x |
| Pamela Bradt Jan-Nov 2020 | CHIEF SCIENTIFIC OFFICER | $309K | $309K | 2020–2020 | 4.1x |
| Ellie Adair | COO & SECRETARY /TREASURER | $305K | $305K | 2021–2024 | 4.1x |
| David Whitrap | VP OF COMMUNICATION AND OU | $296K | $296K | 2018–2021 | 3.9x |
| Foluso Agboola | VP OF RESEARCH | $277K | $277K | 2020–2024 | 3.7x |
| Dan Ollendorf | CHIEF SCIENTIFIC OFFICER | $258K | $196K | 2016–2018 | 3.4x |
| Pamela Bradt | CHIEF SCIENTIFIC OFFICER (SINCE MAR 2019) | $249K | $249K | 2019–2019 | 3.3x |
| Maria Lowe | DIRECTOR OF PHARMACEUTICAL INTELLIGENCE | $229K | $229K | 2020–2024 | 3.1x |
| Richard Chapman | DIRECTOR OF HEALTH ECONOMICS | $227K | $227K | 2016–2020 | 3x |
| Yvette Venable | VP OF PATIENT ENGAGEMENT | $224K | $224K | 2020–2022 | 3x |
| Athelia Tilson Jan-Nov 2020 | VP OF DEVELOPMENT | $214K | $214K | 2020–2020 | 2.8x |
| Melanie Whittington | DIRECTOR OF HEALTH ECONOMICS | $209K | $209K | 2021–2022 | 2.8x |
| Athelia Tilson | VP OF DEVELOPMENT | $198K | $198K | 2019–2019 | 2.6x |
| Anita Chan | FINANCE DIRECTOR | $193K | $193K | 2018–2024 | 2.6x |
| Liis Shea | SENIOR PROGRAM DIRECTOR | $188K | $188K | 2024–2024 | 2.5x |
| Amanda Mehlman | DIRECTOR OF STRATEGIC PARTNERSHIPS | $172K | $172K | 2024–2024 | 2.3x |
| William Dreitlein | DIR OF PHARMACEUTICAL INTELLIGENCE | $172K | $172K | 2016–2018 | 2.3x |
| Max Lee | PHARMACEUTICAL INTELLIGENC | $163K | $163K | 2023–2024 | 2.2x |
| Abigail Wright | DIRECTOR, EVIDENCE SYNTHESIS | $159K | $159K | 2024–2024 | 2.1x |
| Alexandra Ellis | SENIOR SCIENTIST, HTA | $150K | $0 | 2018–2018 | 2x |
| Mitchell Stein | POLICY & COMMUNICATIONS DIRECTOR | $137K | $0 | 2016–2016 | 1.8x |
| Shahram Ashton Moradi | HEALTH ECONOMIST | $134K | $0 | 2022–2022 | 1.8x |
| Meaghan Cummings | SPECIAL ASSISTANT TO THE PRESIDENT | $130K | $0 | 2023–2023 | 1.7x |
| Varun Kumar | ASSOC DIR OF HEALTH ECON. (UNTIL OCT '19) | $130K | $0 | 2017–2019 | 1.7x |
| Sonya Khan | PROGRAM DIRECTOR | $124K | $0 | 2016–2017 | 1.6x |
| Catherine Koola Fischer | DIR. OF PATIENT ENGAGEMENT | $122K | $0 | 2023–2023 | 1.6x |
| Linda Goler Blount | DIRECTOR | $2K | $0 | 2023–2023 | 0x |
| Mark Skinner | DIRECTOR | $500 | $0 | 2022–2022 | 0x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 8 | $254K | $560K | $1.5M |
| 2017 | 8 | $256K | $482K | $1.5M |
| 2018 | 10 | $263K | $525K | $1.8M |
| 2019 | 9 | $291K | $572K | $2.0M |
| 2020 | 11 | $325K | $555K | $2.3M |
| 2021 | 11 | $289K | $572K | $2.6M |
| 2022 | 12 | $292K | $593K | $2.6M |
| 2023 | 12 | $318K | $602K | $2.2M |
| 2024 | 11 | $273K | $526K | $3.0M |
Email Alerts
Get notified about EVIDENCE FOR HEALTHCARE IMPROVEMENT
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.